Search Results - Lucie Jolly
- Showing 1 - 5 results of 5
-
1
-
2
Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs relea... by Amir Boufenzer, Kévin Carrasco, Lucie Jolly, Benjamin Brustolin, Elisa Di-Pillo, Marc Derive, Sébastien Gibot
Published 2021Artigo -
3
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study by Caroline Laroye, Amir Boufenzer, Lucie Jolly, Lisiane Cunat, Corentine Alauzet, Jean‐Louis Merlin, Clémence Yguel, Danièle Bensoussan, Loïc Reppel, Sébastien Gibot
Published 2019Artigo -
4
sTREM-1 is a specific biomarker of TREM-1 pathway activation by Lucie Jolly, Kévin Carrasco, Margarita Salcedo‐Magguilli, Jean–Jacques Garaud, Simon Lambden, Tom van der Poll, Alexandre Mebazaa, Pierre‐François Laterre, Sébastien Gibot, Amir Boufenzer, Marc Derive
Published 2021Carta -
5
TREM-1 multimerization is essential for its activation on monocytes and neutrophils by Kévin Carrasco, Amir Boufenzer, Lucie Jolly, Hélène Le Cordier, Guanbo Wang, Albert J. R. Heck, Adelheid Cerwenka, Emilie Vinolo, Alexis Nazabal, Alexandre Kriznik, Pierre Launay, Sébastien Gibot, Marc Derive
Published 2018Artigo
Search Tools:
Related Subjects
Biology
Cell biology
Biochemistry
Immunology
Chemistry
Inflammation
Medicine
Receptor
Sepsis
Cancer research
Immune system
Innate immune system
Biomarker
Biotechnology
Bone marrow
Computational biology
Downregulation and upregulation
Ectodomain
Endothelial activation
Endothelial dysfunction
Endothelial stem cell
Endothelium
Gene
In vitro
In vivo
Internal medicine
Intracellular
Mesenchymal stem cell
Myeloid
Neutrophil extracellular traps